| UniProt ID | ZN131_HUMAN | |
|---|---|---|
| UniProt AC | P52739 | |
| Protein Name | Zinc finger protein 131 | |
| Gene Name | ZNF131 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 623 | |
| Subcellular Localization | Nucleus . Sumoylation does not affect nuclear localization. | |
| Protein Description | Plays a role during development and organogenesis as well as in the function of the adult central nervous system (By similarity). May be involved in transcriptional regulation as a repressor of ESR1/ER-alpha signaling.. | |
| Protein Sequence | MEAEETMECLQEFPEHHKMILDRLNEQREQDRFTDITLIVDGHHFKAHKAVLAACSKFFYKFFQEFTQEPLVEIEGVSKMAFRHLIEFTYTAKLMIQGEEEANDVWKAAEFLQMLEAIKALEVRNKENSAPLEENTTGKNEAKKRKIAETSNVITESLPSAESEPVEIEVEIAEGTIEVEDEGIETLEEVASAKQSVKYIQSTGSSDDSALALLADITSKYRQGDRKGQIKEDGCPSDPTSKQVEGIEIVELQLSHVKDLFHCEKCNRSFKLFYHFKEHMKSHSTESFKCEICNKRYLRESAWKQHLNCYHLEEGGVSKKQRTGKKIHVCQYCEKQFDHFGHFKEHLRKHTGEKPFECPNCHERFARNSTLKCHLTACQTGVGAKKGRKKLYECQVCNSVFNSWDQFKDHLVIHTGDKPNHCTLCDLWFMQGNELRRHLSDAHNISERLVTEEVLSVETRVQTEPVTSMTIIEQVGKVHVLPLLQVQVDSAQVTVEQVHPDLLQDSQVHDSHMSELPEQVQVSYLEVGRIQTEEGTEVHVEELHVERVNQMPVEVQTELLEADLDHVTPEIMNQEERESSQADAAEAAREDHEDAEDLETKPTVDSEAEKAENEDRTALPVLE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Ubiquitination | QEFPEHHKMILDRLN HHCHHHHHHHHHHHH | 29.55 | - | |
| 49 | Ubiquitination | GHHFKAHKAVLAACS CCHHHHHHHHHHHHH | 45.08 | - | |
| 57 | Acetylation | AVLAACSKFFYKFFQ HHHHHHHHHHHHHHH | 39.10 | 26051181 | |
| 93 | Acetylation | IEFTYTAKLMIQGEE HHHEEEEEEEECCHH | 30.68 | 30593573 | |
| 126 | Ubiquitination | KALEVRNKENSAPLE HHHHHCCCCCCCCCC | 47.94 | - | |
| 139 | Acetylation | LEENTTGKNEAKKRK CCCCCCCCHHHHHHH | 49.90 | 26051181 | |
| 198 | Ubiquitination | ASAKQSVKYIQSTGS HHHHHHHHHHHCCCC | 41.71 | - | |
| 203 | Phosphorylation | SVKYIQSTGSSDDSA HHHHHHCCCCCCHHH | 25.38 | 28348404 | |
| 205 | Phosphorylation | KYIQSTGSSDDSALA HHHHCCCCCCHHHHH | 30.59 | 28348404 | |
| 206 | Phosphorylation | YIQSTGSSDDSALAL HHHCCCCCCHHHHHH | 46.94 | 26657352 | |
| 209 | Phosphorylation | STGSSDDSALALLAD CCCCCCHHHHHHHHH | 30.12 | 28348404 | |
| 218 | Phosphorylation | LALLADITSKYRQGD HHHHHHHHHHHCCCC | 21.51 | - | |
| 219 | Phosphorylation | ALLADITSKYRQGDR HHHHHHHHHHCCCCC | 28.20 | - | |
| 220 | Ubiquitination | LLADITSKYRQGDRK HHHHHHHHHCCCCCC | 35.48 | - | |
| 231 | Ubiquitination | GDRKGQIKEDGCPSD CCCCCCCCCCCCCCC | 41.69 | - | |
| 237 | Phosphorylation | IKEDGCPSDPTSKQV CCCCCCCCCCCCCCC | 61.37 | 28985074 | |
| 265 | Ubiquitination | KDLFHCEKCNRSFKL HHHHCCHHCCCHHHE | 42.05 | - | |
| 282 | Phosphorylation | HFKEHMKSHSTESFK HHHHHHHHCCCCCCE | 18.33 | 25278378 | |
| 284 | Phosphorylation | KEHMKSHSTESFKCE HHHHHHCCCCCCEEE | 40.75 | 25278378 | |
| 285 | Phosphorylation | EHMKSHSTESFKCEI HHHHHCCCCCCEEEE | 30.17 | 25278378 | |
| 287 | Phosphorylation | MKSHSTESFKCEICN HHHCCCCCCEEEECC | 30.05 | 25278378 | |
| 289 | Sumoylation | SHSTESFKCEICNKR HCCCCCCEEEECCHH | 39.99 | - | |
| 289 | Sumoylation | SHSTESFKCEICNKR HCCCCCCEEEECCHH | 39.99 | 28112733 | |
| 289 | Ubiquitination | SHSTESFKCEICNKR HCCCCCCEEEECCHH | 39.99 | - | |
| 295 | Sumoylation | FKCEICNKRYLRESA CEEEECCHHHHCHHH | 37.70 | 28112733 | |
| 319 | Ubiquitination | LEEGGVSKKQRTGKK HHHCCCCCCCCCCCE | 50.98 | - | |
| 320 | Ubiquitination | EEGGVSKKQRTGKKI HHCCCCCCCCCCCEE | 37.19 | - | |
| 325 | Acetylation | SKKQRTGKKIHVCQY CCCCCCCCEEEEHHH | 48.19 | 20167786 | |
| 326 | Ubiquitination | KKQRTGKKIHVCQYC CCCCCCCEEEEHHHH | 39.11 | - | |
| 344 | Ubiquitination | FDHFGHFKEHLRKHT CCCCHHHHHHHHHHC | 38.25 | - | |
| 351 | Phosphorylation | KEHLRKHTGEKPFEC HHHHHHHCCCCCCCC | 50.50 | 28985074 | |
| 354 | Ubiquitination | LRKHTGEKPFECPNC HHHHCCCCCCCCCCH | 57.25 | - | |
| 372 | Methylation | FARNSTLKCHLTACQ HHHCCCCCEEEEHHH | 21.50 | 83047019 | |
| 372 | Ubiquitination | FARNSTLKCHLTACQ HHHCCCCCEEEEHHH | 21.50 | - | |
| 385 | Ubiquitination | CQTGVGAKKGRKKLY HHCCCCCCCCCCCCC | 50.24 | - | |
| 385 | Acetylation | CQTGVGAKKGRKKLY HHCCCCCCCCCCCCC | 50.24 | 23749302 | |
| 386 | Ubiquitination | QTGVGAKKGRKKLYE HCCCCCCCCCCCCCC | 64.51 | - | |
| 440 | Phosphorylation | NELRRHLSDAHNISE HHHHHHHHHHCCHHH | 26.99 | 27732954 | |
| 467 | Phosphorylation | RVQTEPVTSMTIIEQ EEECCCCCEEEEEEE | 24.40 | 28555341 | |
| 468 | Phosphorylation | VQTEPVTSMTIIEQV EECCCCCEEEEEEEC | 17.73 | 28555341 | |
| 470 | Phosphorylation | TEPVTSMTIIEQVGK CCCCCEEEEEEECCC | 20.69 | 28555341 | |
| 568 | Phosphorylation | EADLDHVTPEIMNQE HCCCCCCCHHHHCHH | 16.28 | 28348404 | |
| 579 | Phosphorylation | MNQEERESSQADAAE HCHHHHHHHHHHHHH | 33.69 | 23663014 | |
| 580 | Phosphorylation | NQEERESSQADAAEA CHHHHHHHHHHHHHH | 25.32 | 23663014 | |
| 600 | Phosphorylation | EDAEDLETKPTVDSE CCHHHHCCCCCCCHH | 50.01 | 23186163 | |
| 601 | Sumoylation | DAEDLETKPTVDSEA CHHHHCCCCCCCHHH | 29.34 | - | |
| 603 | Phosphorylation | EDLETKPTVDSEAEK HHHCCCCCCCHHHHH | 38.20 | 23186163 | |
| 606 | Phosphorylation | ETKPTVDSEAEKAEN CCCCCCCHHHHHHHC | 34.08 | 23186163 | |
| 617 | Phosphorylation | KAENEDRTALPVLE- HHHCCCCCCCCCCC- | 44.88 | 20860994 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN131_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 601 | K | Sumoylation |
| 22467880 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN131_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...